Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
CA 2486141 A1 · Owner: Zeldis, Jerome B. · Inventors: Zeldis, Jerome B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by undesired angiogenesis are , disclosed. Specific methods encompass the administration of a selective cytokine inhibitory drug alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy radiation therapy, hormonal , therapy, biological therapy or immunotherapy which comprise the administration of a selective cytokine inhibitory drug. Pharmaceutical compositions single , unit dosage forms, and kits suitable for use in methods of the invention are …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 16, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 16, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 16, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.